Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A high-affinity fully human anti-IL-6 mAb, 1339, for the treatment of multiple myeloma.

A high-affinity fully human anti-IL-6 mAb, 1339, for the treatment of multiple myeloma. Clin Cancer Res. 2009 Dec 01; 15(23):7144-52.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.